Long‐term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease

OBJECTIVE: To examine long‐term safety and efficacy of bosentan—an oral dual endothelin receptor antagonist—in patients with pulmonary hypertension associated with congenital heart disease or Eisenmenger's syndrome. DESIGN: Retrospective study. SETTING: Tertiary cardiology referral centre. PATI...

Full description

Saved in:
Bibliographic Details
Main Authors: Diller, Gerhard‐Paul, Dimopoulos, Konstantinos, Kaya, Mehmet G, Harries, Carl, Uebing, Anselm, Li, Wei, Koltsida, Evdokia, Gibbs, J Simon R, Gatzoulis, Michael A
Format: Artigo
Language:Inglês
Published: BMJ Group 2007
Subjects:
Pulmonary Hypertension
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994431/
https://ncbi.nlm.nih.gov/pubmed/17639112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.089185
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items